Therapy for High Neuroticism: What Treatment Can and Cannot Change
Updated: Oct 8
Author: Ukrainian Psychological Hub · Published: September 30, 2026 · Editorial Policy
High neuroticism is a personality trait pattern, not a psychiatric diagnosis and not a disease that has to be cured. Therapy can nevertheless be useful when emotional tendencies associated with higher neuroticism—frequent distress, threat sensitivity, worry, rumination, avoidance, difficulty recovering from stress, or intense reactions to uncertainty—are causing suffering or interfering with daily life. Treatment can also be appropriate when a diagnosable mental health condition coexists with higher neuroticism.
The evidence supports a more precise conclusion than the popular promise to “become less neurotic.” Personality measures can change during psychological treatment, and neuroticism or its inverse, emotional stability, is one of the Big Five domains that has shown comparatively large treatment-associated change in the intervention literature. A major meta-analysis of 207 studies found personality-trait change during interventions, with emotional stability showing the largest average shift among the Big Five domains (Roberts et al., 2017). But a lower neuroticism score after therapy can reflect several processes at once: genuine trait change, reduced psychiatric symptoms, temporary state improvement, different self-perception, or some combination of these.
Therapy may change how a person responds to emotions, stress, uncertainty, bodily sensations, intrusive thoughts, interpersonal threat, and avoidance. It may also change scores on validated neuroticism measures. It cannot guarantee that a temperament will be erased, that a person will move to an “average” percentile, or that a brief reduction in distress represents permanent personality transformation.
For the broader personality-science definition of the construct, see Neuroticism: What It Is in the Big Five Personality Model. For the relationship between the trait and psychopathology, see Neuroticism and Mental Health: Why the Trait Is a Transdiagnostic Risk Factor.
The short answer: can therapy reduce high neuroticism?
For the broader evidence on personality malleability across development and intervention, see Can Neuroticism Change? Personality Development, Therapy, and Evidence.
Yes. Therapy can be associated with reductions in measured neuroticism, and some evidence indicates that treatment designed to target processes closely related to neuroticism can produce changes beyond simple symptom relief. The strongest conclusion is not that psychotherapy “cures” neuroticism. It is that personality traits are more changeable than older fixed-trait assumptions suggested while still showing meaningful stability across time.
The best-known broad synthesis is the systematic review and meta-analysis by Roberts and colleagues. Across 207 intervention studies, personality-trait measures changed over an average intervention period of about 24 weeks, with an overall average change of approximately d = 0.37. Emotional stability—the opposite pole of neuroticism—showed the largest treatment-associated change among the Big Five domains. Change was not confined to one therapy brand and could persist at follow-up, although studies varied greatly in design, population, treatment target, personality instrument, and methodological strength (Roberts et al., 2017).
More targeted trials provide a second line of evidence. In a randomized trial of 223 treatment-seeking adults with principal anxiety disorders, the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders produced lower post-treatment neuroticism scores than both symptom-focused cognitive behavioral protocols and a waitlist. Neuroticism was measured with the 12-item Neuroticism subscale of the Eysenck Personality Questionnaire Revised–Short Form (EPQR-S), so the result should be interpreted within that instrument rather than treated as a universal “neuroticism score.” The differences at week 16 were modest but statistically significant and remained after the researchers controlled for concurrent fluctuations in anxiety and depressive symptoms (Sauer-Zavala et al., 2021).
Newer work has sharpened the state-versus-trait question. A clinical study following people through up to 12 sessions of the Unified Protocol found evidence consistent with state-level change earlier in treatment and more trait-like change by later sessions. A subsequent randomized study of 70 adults with emotional disorders found that, after accounting for anxiety and depressive symptoms, significant reductions in neuroticism were not evident during the first six sessions but emerged during sessions 7–12 in the full-duration condition (Stumpp, Southward, & Sauer-Zavala, 2024; Stumpp et al., 2026).
Together, these findings support the possibility of treatment-associated trait change while warning against equating every early score reduction with durable personality change.
What “high neuroticism” means in therapy
Neuroticism is a continuous personality dimension. People differ in their typical tendency to experience negative emotions and to react strongly to threat, frustration, uncertainty, and loss. The trait is associated with many forms of psychological distress at the population level, but it is not itself a diagnosis. Reviews describe neuroticism as a broad, nonspecific vulnerability marker that overlaps with risk for multiple common mental disorders without identifying which disorder, if any, an individual has (Lahey, 2009; Ormel et al., 2013).
A therapist should therefore not treat a personality-test score as though it were a diagnosis. A high raw score, standardized score, or percentile only has meaning relative to the specific instrument, scoring method, normative sample, and population. The NEO PI-R, NEO-FFI, BFI-2 Negative Emotionality domain, IPIP-based inventories, and Eysenck measures do not use interchangeable scales. Even when two instruments represent a similar broad domain, their item content and facet emphasis differ.
High neuroticism can enter therapy in several ways. It may be a background personality tendency in a person seeking treatment for a specific disorder. It may be part of chronic stress sensitivity without a current psychiatric diagnosis. It may appear in a personality inventory used for assessment. Or it may be a label a person adopts after taking an online Big Five test. Those situations require different clinical questions.
A useful starting point is not “How do I cure my neuroticism?” but “Which recurring patterns are causing distress or limiting my life?” For one person the answer may be worry and avoidance. For another it may be rumination after social interactions, difficulty tolerating uncertainty, rapid escalation during conflict, or prolonged recovery after ordinary stress. The therapeutic target becomes the pattern and its consequences rather than the existence of a high trait score.
Neuroticism is not the same as negative affect, anxiety, or psychiatric symptoms
In Big Five language, neuroticism and emotional stability describe opposite directions of the same broad trait dimension in many models. The BFI-2 uses the domain label Negative Emotionality rather than Neuroticism. A person can therefore encounter different labels across instruments without those instruments being identical.
Negative affect is related but conceptually narrower. It often refers to unpleasant emotional experience at a particular moment or over a specified period. Neuroticism is a broader dispositional tendency across situations and time. Anxiety and depression symptoms can fluctuate over days or weeks, while personality measures are intended to characterize more enduring individual differences. Current symptoms can still influence how people answer trait questionnaires, which is one reason researchers try to separate state effects from trait change.
If a person enters treatment during a severe anxious or depressive episode and later feels substantially better, some items on a neuroticism inventory may also be endorsed less strongly. That could reflect meaningful trait change, removal of a state-related distortion, or both. Stronger studies address this by controlling for symptom change, using repeated assessments, examining follow-up, or modeling state and trait components rather than assuming that a pre-to-post score difference has only one explanation.
When therapy for high neuroticism makes sense
Therapy makes sense when the person has a treatment goal that can be expressed in terms of distress, functioning, behavior, relationships, or a clinically assessed condition. A personality score can help describe the context, but it does not have to become the treatment target.
Someone with high neuroticism may want to recover more quickly after setbacks, spend less time worrying, stop organizing life around avoidance, respond less automatically to bodily sensations, communicate more effectively when feeling threatened, or reduce repetitive self-criticism. These are concrete therapeutic goals. They can be monitored through behavior and functioning even if the person’s broad personality profile remains recognizably their own.
Therapy is also appropriate when an assessment identifies a mental disorder requiring treatment. Higher neuroticism is statistically associated with anxiety and depressive disorders and with comorbidity, but the trait cannot determine the diagnosis. Symptoms, duration, impairment, differential diagnosis, medical context, and clinical history must be evaluated on their own terms. Neuroticism and Mental Health explains why the trait can function as a transdiagnostic risk factor without becoming a transdiagnostic diagnosis.
If a person has a high neuroticism score but little distress, good functioning, stable relationships, and no meaningful problem they want to change, the score alone does not create a clinical need for psychotherapy.
What therapy can change
Psychotherapy can target processes that help maintain distress and that are often associated with higher neuroticism. Depending on the person and the treatment model, these may include avoidance of emotions, rigid threat interpretations, intolerance of uncertainty, repetitive negative thinking, behavioral withdrawal, safety behaviors, catastrophic interpretations of bodily sensations, self-critical responses, and difficulty shifting attention or behavior after emotional activation.
Therapy can also change learned responses to emotion. A person may still notice anxiety quickly while becoming less likely to treat anxiety as evidence that danger is imminent. They may still experience anger while becoming better able to delay an impulsive response. They may still feel self-conscious while approaching situations they previously avoided. These changes matter even when the trait has not been “removed.”
Another plausible target is regulation flexibility. Higher neuroticism is associated with differences in how people use emotion-regulation strategies, but effective regulation is not one technique applied constantly. It involves choosing responses that fit the situation, goals, intensity, and controllability of the event. Neuroticism and Emotion Regulation: Strategies, Flexibility, and Distress reviews this relationship in detail.
Stress appraisal and recovery can change as well. Higher neuroticism is associated with greater perceived stress and stronger negative emotional reactivity on average, but these are probabilistic patterns. Therapy can work on appraisal, coping, exposure to avoided situations, behavioral routines, and recovery after stress without needing to redefine the person’s entire personality. See Neuroticism and Stress: Perceived Stress, Reactivity, and Recovery.
Finally, psychotherapy can be associated with change in trait questionnaires themselves. That is the most direct answer to the search query, but it should be treated as one outcome among several. A lower neuroticism score is meaningful only when the same instrument and scoring procedure are used appropriately, and it is most clinically informative when paired with changes in symptoms, functioning, behavior, and quality of life.
Four different kinds of change are often confused
State fluctuation
State fluctuation is a temporary shift in mood, arousal, stress, or symptoms. A good week, a reduction in acute anxiety, relief after a crisis, or recovery from a depressive episode can alter how a person describes themselves. State fluctuation can be important and welcome, but it is not automatically evidence that a broad personality trait has changed.
Symptom reduction
Symptoms belong to a clinical problem or syndrome rather than to the Big Five construct itself. Worry, panic, depressed mood, compulsions, trauma symptoms, insomnia, or somatic distress can improve during treatment. Because symptoms overlap statistically and phenomenologically with negative emotionality, symptom improvement can influence neuroticism scores. Symptom change should therefore be measured directly rather than inferred from personality change.
Mean-level personality change
Mean-level change refers to average change in a trait within a group over time. If a treatment group shows lower average neuroticism after therapy, that is a mean-level result. It does not tell us that every participant changed, that everyone changed by the same amount, or that a particular individual’s change exceeds measurement error.
Individual trait change
Individual change asks whether one person’s typical pattern has shifted in a meaningful and relatively enduring way. Demonstrating that requires more than a single post-treatment score. Repeated measurement, reliable-change methods where appropriate, behavior across contexts, and follow-up can provide stronger evidence. A person can also improve substantially in life without showing a large change on a broad trait measure.
What the intervention meta-analysis actually shows
The Roberts et al. meta-analysis is frequently summarized as proof that therapy changes personality. Its findings are important, but the details matter. The review pooled studies in which personality measures were tracked across interventions. Designs included randomized experiments as well as pre–post studies, and interventions differed in purpose, duration, population, and method. The average intervention lasted roughly 24 weeks, and personality measures changed by an average standardized amount of about d = 0.37. Emotional stability showed the largest average change among the Big Five domains (Roberts et al., 2017).
The analysis also found that people treated for anxiety disorders showed particularly large personality-measure changes. That result is consistent with the conceptual and measurement overlap between anxiety-related distress and neuroticism. It is also a reason for caution: when presenting symptoms and the trait share content, treatment-related symptom reduction can contribute to observed trait-score change.
The review nevertheless found evidence that could not be reduced to a trivial short-lived mood effect. Changes appeared across different study designs and could persist beyond the intervention period. The strongest interpretation is that therapeutic experiences can contribute to personality-trait change, while the magnitude and mechanism depend on what is treated, how personality is measured, how long follow-up lasts, and how state effects are handled.
The Unified Protocol: the clearest targeted clinical evidence
For the protocol-specific evidence review, see Unified Protocol and Neuroticism: A Transdiagnostic Treatment Approach.
The Unified Protocol is an emotion-focused cognitive behavioral treatment developed for emotional disorders. It targets transdiagnostic processes such as aversive reactions to emotion, avoidance, inflexible emotion-driven behavior, and maladaptive responses to internal experience. In this literature, neuroticism or negative emotionality is treated as a broad temperamental vulnerability rather than as a standalone diagnosis.
The 223-participant randomized trial is especially relevant because it compared the Unified Protocol with established symptom-focused CBT protocols and a waitlist. Participants had principal anxiety disorders, and most had comorbid diagnoses. Neuroticism was assessed with the EPQR-S Neuroticism scale. At week 16, the Unified Protocol group had lower neuroticism scores than the symptom-focused CBT group (d = −0.32) and the waitlist group (d = −0.43). The difference between the Unified Protocol and symptom-focused CBT remained after statistical adjustment for concurrent anxiety and depressive symptoms (Sauer-Zavala et al., 2021).
That does not establish that the Unified Protocol is the universally best therapy for anyone who scores high on neuroticism. The sample consisted of treatment-seeking people with anxiety disorders, not a random sample of high-neuroticism adults without disorders. The outcome was a specific Eysenck measure. The effect sizes were not enormous. And the study compared treatment packages, so it does not prove which individual component caused the trait change.
What it does provide is unusually direct evidence that a therapy designed around transdiagnostic emotional processes can alter measured neuroticism beyond what was observed with symptom-focused protocols in that trial.
What newer studies say about state change and trait change
A central methodological question is when a lower neuroticism score starts to look like durable trait change rather than a temporary state effect. Stumpp, Southward, and Sauer-Zavala tested this question across up to 12 weekly sessions of the Unified Protocol in 38 adults with a primary emotional disorder. Their models suggested state-level changes by session 6 and trait-level changes by session 12. Within-person reductions in neuroticism were related bidirectionally to anxiety change and preceded some session-to-session improvements in depression (Stumpp, Southward, & Sauer-Zavala, 2024).
The sample was small, so the study is better read as a mechanism-focused contribution than as a definitive estimate of treatment effects. Its value lies in showing why repeated measurement across treatment is more informative than a simple before-and-after comparison.
A later randomized study with 70 adults tested six versus 12 sessions and different module sequences. During the first six sessions, changes in neuroticism did not significantly differ by treatment duration. Once depressive and anxiety symptoms were controlled, there was no significant neuroticism change during those first six sessions. In the 12-session condition, significant reductions emerged during sessions 7–12 (Stumpp et al., 2026).
This does not establish a universal “12-session rule.” Treatment duration cannot be prescribed from a single study because clinical needs, diagnoses, severity, treatment model, adherence, therapist factors, and measurement schedules vary. It does, however, reinforce a useful principle: durable personality change may require repeated experiences over time, while early improvement can be dominated by changing states and symptoms.
Does ordinary CBT lower neuroticism?
For the CBT-specific evidence review, see CBT and Neuroticism: What the Evidence Shows.
CBT is a broad family of therapies rather than one standardized intervention. Different CBT protocols target different disorders and mechanisms. It is therefore inaccurate to ask whether “CBT” as a single uniform treatment lowers neuroticism in every population.
The broad intervention meta-analysis found personality change across therapeutic approaches and did not identify therapy type as a strong general moderator of the amount of change (Roberts et al., 2017). That supports the possibility that neuroticism-related trait measures can shift during many successful interventions, especially when treatment changes recurring emotional and behavioral patterns.
At the same time, the 223-person trial found greater post-treatment reduction on the EPQR-S Neuroticism scale with the Unified Protocol than with the symptom-focused CBT protocols used as comparators (Sauer-Zavala et al., 2021). This is evidence for that comparison in that clinical sample, not evidence that conventional CBT is ineffective or that every transdiagnostic protocol outperforms every disorder-specific CBT.
The practical conclusion is that therapy should be selected for the person’s actual clinical problem and goals. If the explicit aim is to alter transdiagnostic emotional patterns closely related to neuroticism, a treatment designed around those processes has a clearer conceptual fit than treating a high trait score in isolation.
How therapy may produce personality change
Traits are inferred from recurring patterns of emotion, cognition, motivation, and behavior across time and situations. If therapy repeatedly changes those patterns, trait-level self-description can change as well.
One route is exposure to previously avoided internal and external experiences. Repeatedly approaching uncertainty, bodily sensations, difficult conversations, or feared situations can alter expectations about what emotions mean and what a person can tolerate. Another route is changing emotion-driven behavior: learning that anxiety does not require escape, shame does not require withdrawal, and anger does not require immediate confrontation.
A third route is metacognitive and attentional change. Therapy may reduce time spent in repetitive worry or rumination, increase the ability to notice thoughts without automatically treating them as facts, and improve the capacity to redirect attention. A fourth route is behavioral learning: activity patterns, social approach, problem solving, and repeated coping success can change the environmental feedback that sustains distress.
No single mechanism has been established as the universal cause of neuroticism change. A 2026 systematic review of nonclinical interventions found 99 articles using a heterogeneous range of strategies and constructs. The authors organized these into a taxonomy of 19 intervention strategies precisely because the field still lacks a single, well-validated mechanism map for intentional neuroticism change (Wright et al., 2026).
Therapy may change the person without making every negative emotion disappear
Lower neuroticism does not mean emotional numbness. Negative emotions are part of normal psychological functioning. Fear can orient attention toward danger. Sadness can accompany loss. Anger can signal perceived violation or obstruction. Concern can motivate preparation.
The clinically relevant problem is often the frequency, intensity, persistence, interpretation, or behavioral consequences of emotion. Someone may still experience strong emotion while becoming less likely to catastrophize it, avoid it, act impulsively because of it, or remain activated for hours afterward. Such changes can improve functioning even when the person remains more emotionally sensitive than average.
This is one reason High Neuroticism: Meaning, Traits, Strengths, and Risks treats high neuroticism as a dimensional profile rather than a defect. Therapy is about increasing workable choices and reducing suffering, not imposing one ideal personality configuration.
How long does it take to change neuroticism?
There is no evidence-based universal number of sessions required to “lower neuroticism.” The intervention literature includes very different durations, populations, and measures. The Roberts meta-analysis found change across interventions averaging roughly 24 weeks, but an average from heterogeneous studies is not a treatment prescription (Roberts et al., 2017).
The more focused Unified Protocol studies suggest that timing matters. In the 2024 study, early changes looked more state-like and later changes more trait-like. In the 2026 randomized study, the full 12-session condition showed significant reductions during sessions 7–12 after symptom adjustment, whereas the first six sessions did not provide equivalent evidence for trait change (Stumpp, Southward, & Sauer-Zavala, 2024; Stumpp et al., 2026).
The most useful way to think about duration is longitudinal rather than magical: repeated practice and repeated corrective experiences are more plausible mechanisms of enduring personality change than a single insight or a short-lived improvement in mood.
Can medication change neuroticism?
For the medication-specific clinical boundary, see Medication for Neuroticism? Why a Personality Trait Is Not Treated Like a Diagnosis.
No medication is prescribed simply because a person has “high neuroticism.” Neuroticism is a personality trait, not a medication indication. Pharmacologic treatment is chosen for a diagnosable clinical condition, symptom pattern, medical context, risks, contraindications, and patient preferences.
A placebo-controlled depression trial randomized adults with moderate to severe major depressive disorder to paroxetine, placebo, or cognitive therapy. Personality was measured with the NEO Five-Factor Inventory. The paroxetine group showed greater reported change in neuroticism than the placebo group even after controlling statistically for depression improvement, and cognitive therapy also showed personality change relative to placebo on some analyses (Tang et al., 2009).
This study does not mean that an SSRI should be taken to modify a Big Five score. It studied treatment of major depressive disorder, used a specific medication and instrument, and was designed around a clinical population. Medication decisions belong to treatment of the underlying disorder or symptoms, not to an isolated personality-test result.
A small randomized study of 39 adults with comorbid anxiety and depressive disorders who were already taking stable SSRI doses found that adding the Unified Protocol was associated with improvement in several neuroticism-related constructs, including negative affect, anxiety sensitivity, experiential avoidance, and intolerance of uncertainty, compared with continuing SSRI alone (Zemestani et al., 2022). Those outcomes are related to neuroticism, but they should not be collapsed into one universal trait score.
What therapy cannot promise
Therapy cannot promise that a person will stop having negative emotions, never worry again, or become temperamentally identical to someone low in neuroticism. It cannot guarantee movement to a specific percentile on a personality test. It cannot convert a high score into a diagnosis, and it cannot use a lower post-treatment score as proof that a diagnosis has disappeared.
Therapy also cannot establish that every improvement is a trait change. A person may feel substantially better because a depressive episode remits, panic becomes less frequent, sleep improves, a crisis resolves, or a stressful environment changes. Those are genuine outcomes. Calling all of them “personality change” would make the construct less precise rather than more useful.
Nor can therapy guarantee permanence. Trait change is inferred from relative stability across time and contexts. Follow-up matters. A person can show a meaningful post-treatment reduction that later attenuates, or maintain behavioral gains despite some return of distress. Both possibilities are compatible with contemporary personality science.
How to measure progress without confusing a score with a diagnosis
When neuroticism is measured in treatment, the same validated instrument should generally be used across repeated assessments. Switching from the NEO-FFI to an IPIP scale or from the BFI-2 Negative Emotionality domain to an Eysenck neuroticism scale makes direct score comparisons difficult because the instruments differ in items, scoring, facet structure, and norms.
Raw scores should not be interpreted as universal severity categories. A percentile depends on the normative reference group. A standardized score depends on the scoring method and population. A “high” score in one system does not map automatically onto a “high” score in another.
Personality measurement should be paired with direct outcomes. If the treatment goal is to reduce avoidance, measure approach behavior. If the goal is to reduce worry, measure worry and interference. If the goal is better recovery from stress, track recovery itself. If a clinical disorder is present, use validated disorder-specific symptom measures and clinical assessment rather than inferring treatment response from neuroticism alone.
For research-quality claims about trait change, repeated measurements and follow-up are especially valuable. They help distinguish a stable shift in typical functioning from state effects that occur when symptoms temporarily rise or fall.
What if your Big Five test says you are very high in neuroticism?
A result can be informative, but it should first be interpreted within the test that produced it. Was the instrument validated? Which neuroticism or negative-emotionality scale did it use? Was the score raw, standardized, or percentile-based? Which normative group was used? Was the test designed for research, personality description, screening, entertainment, or clinical assessment?
Next, ask whether the result corresponds to a problem in your life. A high score may fit a longstanding pattern of strong emotional reactivity and stress sensitivity. It may also be elevated by a period of anxiety, depression, sleep disruption, grief, illness, or acute stress. A single score cannot separate these explanations.
If there is no significant distress or impairment, there is no clinical rule that says the trait must be treated. If there is distress or functional difficulty, therapy can focus on the specific patterns involved. The score can provide context, but it does not determine what treatment you need.
How to choose a therapy goal
A strong therapy goal is behavioral and functional enough to observe. “I want to become less neurotic” is broad. “I want to stop cancelling plans whenever I anticipate embarrassment,” “I want to spend less of the evening replaying work mistakes,” “I want to recover from conflict without two days of rumination,” or “I want to tolerate uncertainty without checking repeatedly” creates a clearer target.
This translates a broad trait into processes that can be changed, practiced, and monitored. Over time, repeated changes in those processes may contribute to a broader personality shift.
It also protects against an unhelpful therapeutic ideal in which normal emotional sensitivity is treated as failure. Some people will remain relatively high in neuroticism compared with others while becoming much more effective at living with emotional intensity.
Should therapy target neuroticism directly or treat the underlying disorder?
When a diagnosable disorder is present, treatment planning should be anchored in that clinical condition and the person’s presentation. Neuroticism can help explain broad vulnerability or recurring emotional patterns, but it does not replace disorder-specific assessment.
The Unified Protocol is relevant because it was designed as a transdiagnostic treatment for emotional disorders and explicitly targets processes linked to neuroticism. That makes it a valuable model for understanding trait-focused change. It is still a clinical treatment delivered to people with problems requiring treatment, not a personality optimization procedure for everyone above a percentile threshold.
If there is no disorder but a person wants intentional personality change, the evidence base is newer and more heterogeneous. The 2026 review of nonclinical neuroticism interventions identified 99 articles but emphasized major differences in intervention strategies, constructs, designs, and mechanisms. The field does not yet justify a single standardized “neuroticism reduction protocol” for the general public (Wright et al., 2026).
Does reducing symptoms automatically reduce neuroticism?
No. Symptoms and neuroticism overlap, but their changes can diverge. A person can improve greatly in panic, depression, or compulsive behavior while showing a smaller change in broad trait scores. Conversely, a trait score may decline partly because acute distress has lifted.
The Unified Protocol trial was designed specifically to address this issue. The advantage of the Unified Protocol over symptom-focused CBT on EPQR-S neuroticism remained after controlling for simultaneous anxiety and depressive symptom fluctuations. That finding strengthens the argument that the result was not merely a statistical shadow of symptom improvement, although statistical control cannot answer every causal question (Sauer-Zavala et al., 2021).
The Tang depression trial approached the same problem from another direction. Participants receiving placebo showed substantial depressive symptom improvement but relatively little change in NEO-FFI neuroticism, while the paroxetine group showed greater neuroticism change even after depression improvement was considered (Tang et al., 2009). These findings argue against treating symptom and trait scores as interchangeable.
Can therapy lower neuroticism without a mental disorder?
Possibly, but the evidence is less settled than the clinical-treatment literature might suggest. Intentional personality-change research includes coaching, digital interventions, self-directed exercises, skills training, mindfulness-related programs, and other approaches. Studies vary in whether they actually measure broad neuroticism, emotional stability, a facet, a related construct, or a short-term state.
The 2026 systematic review of interventions for the general public catalogued strategies and proposed a taxonomy for future research rather than producing a simple claim that one technique reliably lowers neuroticism in everyone (Wright et al., 2026).
For a person without a disorder, the most defensible goal is to identify concrete experiences or habits they want to change and choose an evidence-informed intervention for those processes. A later reduction in a validated trait measure can be one indicator of broader change, but it should not become the sole definition of success.
What about mindfulness, acceptance, and emotion-regulation training?
These approaches can target processes related to distress, attention, reactivity, avoidance, and regulation, and some intentional-change studies include them. The evidence should be described at the level actually tested. Improvement in mindfulness, experiential avoidance, intolerance of uncertainty, or negative affect does not automatically prove a durable reduction in broad neuroticism.
This distinction matters because a study of one related construct can quickly become a headline claiming that a technique “changes your personality.” The 2026 intervention review found substantial heterogeneity in the constructs and strategies used across studies, which is precisely why a process-level taxonomy was needed (Wright et al., 2026).
A treatment can still be useful without changing the Big Five domain. If it reduces suffering, improves functioning, or increases flexible behavior, that is clinically meaningful in its own right.
What predicts durable change?
Research does not yet provide a reliable individual-level formula that predicts who will show lasting neuroticism change. Sufficient treatment exposure, repeated practice across contexts, successful modification of avoidance and emotion-driven behavior, improvement that persists after acute symptoms change, and continued use of skills are plausible contributors.
The recent Unified Protocol studies support treatment duration as one potentially relevant factor, but they do not establish a universal threshold. The intervention meta-analysis suggests that personality change can persist at follow-up, but it combines many different treatments and populations. The nonclinical systematic review shows that mechanisms remain an active research problem.
Individual prediction is much weaker than group-level evidence. A therapist or test cannot reliably look at one high neuroticism score and calculate how much that person’s trait will change, how many sessions it will take, or which final percentile they will reach.
What a good outcome can look like
A good outcome may include less avoidance, less time lost to worry or rumination, faster recovery from stress, more flexible emotion regulation, greater willingness to approach uncertainty, fewer emotion-driven decisions, better relationship functioning, or remission of a clinical disorder. It may also include a lower neuroticism score on the same validated measure used at baseline.
These outcomes can occur together, but they do not have to move in lockstep. A person can remain emotionally sensitive and still gain substantial freedom in how they respond. They can become more stable without becoming emotionally flat. They can improve clinically without changing their relative rank compared with peers. They can also show a trait-score shift that becomes clearer only after treatment has been sustained for some time.
The practical meaning of therapy for high neuroticism is therefore not personality erasure. It is increasing the range of responses available when negative emotion appears and reducing the degree to which predictable emotional patterns control behavior and functioning.
Evidence limits
The evidence base has several limitations. Many intervention studies were not originally designed to test personality change. Measures differ across studies. Some samples are small. Treatment-seeking clinical samples are not equivalent to the general population. Self-report personality measures can be affected by current symptoms and self-concept. Follow-up periods vary, and some studies cannot distinguish durable trait change from persistent state change.
Even the strongest targeted findings come from specific treatment models and populations. The randomized Unified Protocol trial involved adults with anxiety disorders and used the EPQR-S neuroticism scale. The 2026 duration study involved 70 adults with emotional disorders. The depression medication trial involved adults with major depressive disorder and used the NEO-FFI. These studies answer important questions, but they do not establish one treatment rule for every person with a high Big Five score.
The newer nonclinical literature is promising but heterogeneous. The 2026 systematic review’s 99 articles covered many intervention strategies and related constructs, making it difficult to identify a single mechanism or universally effective protocol (Wright et al., 2026).
Frequently asked questions
Is high neuroticism a mental disorder?
No. Neuroticism is a dimensional personality trait. Higher scores are associated with increased average risk for several forms of psychological distress, but a trait score does not diagnose anxiety, depression, OCD, PTSD, ADHD, autism, a personality disorder, or another condition.
Can therapy make me less neurotic?
Therapy can be associated with lower scores on validated neuroticism measures, and some studies support treatment-related trait change. The outcome should be understood alongside symptom change, functioning, the specific personality instrument, and follow-up rather than as a guaranteed personality conversion.
What therapy has the strongest direct evidence for changing neuroticism?
The Unified Protocol has particularly direct randomized evidence because it was designed to target transdiagnostic emotional processes linked to neuroticism. In a 223-person anxiety-disorder trial, it produced lower EPQR-S neuroticism scores than symptom-focused CBT protocols and a waitlist at week 16. That evidence applies to the studied clinical population and does not establish one universal best therapy for everyone high in neuroticism.
Does CBT change personality?
Personality measures can change during CBT and other psychological treatments. CBT is a broad family of interventions, so the answer depends on the protocol, target condition, population, duration, and personality measure. A change in symptoms should not automatically be reclassified as a change in personality.
How many therapy sessions does it take to lower neuroticism?
There is no universal number. Recent Unified Protocol research suggests that early changes can be more state-like and that clearer trait-level change may emerge later in treatment. One 2026 study found significant symptom-adjusted reductions during sessions 7–12 in a 12-session condition, but this is not a universal session prescription.
Can medication lower neuroticism?
Some clinical trials have found changes in neuroticism measures during medication treatment for psychiatric disorders. That does not make high neuroticism a medication indication. Medication is prescribed for an underlying clinical condition, not simply to change a Big Five score.
Does a lower neuroticism score prove therapy worked?
No single score proves treatment success. Progress should be evaluated with the same validated measure when possible and alongside symptoms, functioning, behavior, quality of life, and the person’s treatment goals.
Do I need therapy because an online test says I have high neuroticism?
No. A high score alone does not create a diagnosis or a treatment requirement. The important questions are whether the test is valid, how the score was normed, whether the result fits a stable pattern, and whether there is meaningful distress or impairment you want help with.
Can neuroticism change permanently?
Personality traits show both stability and change. Intervention research supports the possibility of enduring changes, but permanence cannot be guaranteed from a short-term score shift. Follow-up and evidence of change across situations are more informative than one post-treatment assessment.
Can I keep my emotional sensitivity and still benefit from therapy?
Yes. Therapy does not require emotional numbness. A person can remain relatively sensitive to stress while becoming more flexible, less avoidant, less controlled by worry or rumination, and faster at recovering after difficult emotions.
Related Articles
References
Lahey, B. B. (2009). Public health significance of neuroticism. American Psychologist, 64(4), 241–256. https://doi.org/10.1037/a0015309
Ormel, J., Jeronimus, B. F., Kotov, R., Riese, H., Bos, E. H., Hankin, B., Rosmalen, J. G. M., & Oldehinkel, A. J. (2013). Neuroticism and common mental disorders: Meaning and utility of a complex relationship. Clinical Psychology Review, 33(5), 686–697. https://doi.org/10.1016/j.cpr.2013.04.003
Roberts, B. W., Luo, J., Briley, D. A., Chow, P. I., Su, R., & Hill, P. L. (2017). A systematic review of personality trait change through intervention. Psychological Bulletin, 143(2), 117–141. https://doi.org/10.1037/bul0000088
Sauer-Zavala, S., Fournier, J. C., Steele, S. J., Woods, B. K., Wang, M., Farchione, T. J., & Barlow, D. H. (2021). Does the Unified Protocol really change neuroticism? Results from a randomized trial. Psychological Medicine, 51(14), 2378–2387. https://doi.org/10.1017/S0033291720000975
Stumpp, N. E., Southward, M. W., & Sauer-Zavala, S. (2024). Assessing theories of state and trait change in neuroticism and symptom improvement in the Unified Protocol. Behavior Therapy, 55(1), 93–105. https://doi.org/10.1016/j.beth.2023.05.005
Stumpp, N. E., Southward, M. W., Hines, A., Kushner, M. L., Schäuffele, C., Fruhbauerova, M., Bridges, E., Rahman, A., & Sauer-Zavala, S. (2026). When and under what circumstances does neuroticism change in the Unified Protocol? Psychotherapy Research, 36(4), 785–796. https://doi.org/10.1080/10503307.2025.2521779
Tang, T. Z., DeRubeis, R. J., Hollon, S. D., Amsterdam, J., Shelton, R., & Schalet, B. (2009). Personality change during depression treatment: A placebo-controlled trial. Archives of General Psychiatry, 66(12), 1322–1330. https://doi.org/10.1001/archgenpsychiatry.2009.166
Wright, A. J., Haehner, P., Hopwood, C. J., & Bleidorn, W. (2026). A systematic review and taxonomy of neuroticism interventions for the general public. Personality Science, 7. https://doi.org/10.1177/27000710261421531
Zemestani, M., Ommati, P., Rezaei, F., & Gallagher, M. W. (2022). Changes in neuroticism-related constructs over the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in patients on an optimal dose of SSRI. Personality Disorders: Theory, Research, and Treatment, 13(2), 171–181. https://doi.org/10.1037/per0000482